Sava Infond’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,200
Closed -$299K 245
2026
Q1
$299K Sell
3,200
-3,230
-50% -$316K 0.04% 170
2025
Q4
$626K Sell
6,430
-1,830
-22% -$173K 0.08% 124
2025
Q3
$732K Sell
8,260
-1,000
-11% -$86.4K 0.1% 112
2025
Q2
$797K Buy
9,260
+760
+9% +$65.4K 0.12% 100
2025
Q1
$775K Sell
8,500
-1,260
-13% -$114K 0.15% 99
2024
Q4
$839K Buy
+9,760
New +$902K 0.15% 92

Other funds holding IXJ

Sava Infond's IXJ Position: Q2 2026 in Review

Sava Infond sold out of iShares Global Healthcare ETF (IXJ) in Q2 2026, closing a stake of 3,200 shares — an estimated $299K sold.

Sava Infond first reported a position in IXJ in Q4 2024 and held it in 6 quarters. The position peaked at $839K in Q4 2024. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Sava Infond reported no remaining iShares Global Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • Sava Infond sold 3,200 iShares Global Healthcare ETF shares in Q2 2026, an estimated $299K.
  • Sava Infond first reported a position in iShares Global Healthcare ETF in Q4 2024 and held it in 6 quarters.
  • Sava Infond's iShares Global Healthcare ETF position peaked at $839K in Q4 2024.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.